Work

Electrophilic Tuning of Novel Pentafluorobenzenesulfonamide Warheads

Year: 2020
Type: dissertation
Abstract: This thesis details research in our lab which identified a novel reactive pentafluorobenzenesulfonamide (PFBS) warhead, delivering four separate projects focused on protecting and tailoring a reactive warhead towards biological nucleophiles and systemic application in vivo. Discovery of AC-3-019, a novel and potent molecule harbouring a modified PFBS group uniquely demonstrated a conformational mechanism that provided suitable pharmacokinetic (PK) stability compared to its predecessors. AC-3-019 was subsequently evaluated in two in-vivo animal models (MB and AML) to assess its anti-cancer ability. In follow-up work, DR-1-055, combined the conformational approach with synergistic electronic tuning of PFBS to deliver another metabolically stable scaffold with enhanced PK parameters. DR-1-055’s enhanced potency is displayed against two in-vivo breast cancer mouse models, as well as in-vivo facial tumour model towards Tasmanian devils. A simplified version of the PFBS bearing an alkyne handle was used in an activity-based protein profiling (ABPP) approach to interrogate its intrinsic reactivity against biological nucleophiles in HeLa cell lysates. Gel-based click experiments were performed to compare reactivity against common covalent cysteine-targeting warheads. Subsequently, a semi-quantitative approach called tandem orthogonal proteolysis-ABPP (TOP-ABPP) demonstrated that the PBFS warhead is cysteine-specific. Lastly, we demonstrated a unique ortho-substitution technique to systematically control the reactivity of PFBS by electronic tuning and applied it towards a known PFBS-containing clinical candidate. Directed-ortho-metalation (DOM) chemistry was used to synthesize ortho-substituted warheads allowing for systematic tuning of reactivity. Finally, Batabulin, a PFBS containing molecule previously failing in phase II clinical trials, was utilized as an example for application of the ortho-substitution platform to potentially rescue a failed clinical candidate.
Language: English
Field: Chemistry
Open Access status: green
OpenAlex ID: W7133034511
Cites: 107
Cited by:
Related to: 10